×
About 2,385 results

ALLMedicine™ Moyamoya Disease Center

Research & Reviews  914 results

Timing of revascularization in ischemic Moyamoya disease: association of early versus d...
https://doi.org/10.1016/j.wneu.2022.07.090
World Neurosurgery; Xu R, Xie ME et. al.

Aug 6th, 2022 - Moyamoya disease (MMD) patients who present primarily with ischemic stroke are known to have higher rates of perioperative strokes as compared with those who present with non-stroke symptoms. The optimal timing for revascularization for these pati...

Long noncoding RNA profile of the intracranial artery in patients with moyamoya disease.
https://doi.org/10.3171/2022.5.JNS22579
Journal of Neurosurgery; Mamiya T, Kanamori F et. al.

Jul 31st, 2022 - Moyamoya disease (MMD) is a rare cerebrovascular disease characterized by progressive stenosis of the internal carotid artery (ICA) and secondary formation of collateral vessels. Revascularization surgery is performed in patients with MMD to preve...

The usefulness and safety of dexmedetomidine for postoperative sedation in pediatric pa...
https://doi.org/10.3171/2022.6.PEDS2241
Journal of Neurosurgery. Pediatrics; Kanamori F, Araki Y et. al.

Jul 29th, 2022 - After revascularization surgery in pediatric patients with moyamoya disease (MMD), resting and avoiding crying is important. However, this inaction is often difficult because of pain or anxiety. Dexmedetomidine (DEX), which has sedative and analge...

Prediction of hemorrhagic cerebral hyperperfusion syndrome after direct bypass surgery ...
https://doi.org/10.3171/2022.5.JNS212838
Journal of Neurosurgery; Pang CH, Lee SU et. al.

Jul 29th, 2022 - The aim of this study was to identify predictive factors for hemorrhagic cerebral hyperperfusion syndrome (hCHS) after direct bypass surgery in adult nonhemorrhagic moyamoya disease (non-hMMD) using quantitative parameters on rapid processing of p...

RNF213 R4810K Variant in Suspected Unilateral Moyamoya Disease Predicts Contralateral P...
https://doi.org/10.1161/JAHA.122.025676
Journal of the American Heart Association; Ok T, Jung YH et. al.

Jul 26th, 2022 - Background Early-stage unilateral moyamoya disease (MMD) is difficult to discriminate from isolated intracranial atherosclerotic stenosis, and identification of contralateral progression may aid in the diagnosis of MMD. The RNF213 (ring finger pro...

see more →

Guidelines  1 results

Spontaneous occlusion of the circle of Willis in children: pediatric moyamoya summary w...
https://doi.org/10.3171/2011.12.PEDS1172
Journal of Neurosurgery. Pediatrics; Smith ER, Scott RM

Apr 3rd, 2012 - Moyamoya is a progressive arteriopathy of unknown origin affecting the branches of the internal carotid artery (ICA). The arteriopathy can present as an isolated medical condition, affecting both sides of the brain ("moyamoya disease") or can be u...

see more →

Clinicaltrials.gov  27 results

Effect of Recombinant Human EPO on the Postoperative Neurologic Outcome in Pediatric Moyamoya Patients
https://clinicaltrials.gov/ct2/show/NCT03882060

Jun 3rd, 2022 - This study evaluates the effect of recombinant human erythropoietin (rHuEPO) on the neovascularization of pediatric moyamoya disease patients. rHuEPO will be administrated during perioperative period of the first revascularization surgery. Primary...

Long-term Outcomes of Conservative Management in Patients With Moyamoya Disease and Their First-degree Relatives (LAMORA)
https://clinicaltrials.gov/ct2/show/NCT05332756

Jun 2nd, 2022 - Moyamoya disease (MMD) is a chronic occlusive-stenosis cerebrovascular disease that characterized by the stenosis of internal carotid artery termination and the formation of net-like vessel. It is a multifactorial disease caused by genetic, inflam...

The Role of m6A RNA Modification in Moyamoya Disease
https://clinicaltrials.gov/ct2/show/NCT04696094

Feb 17th, 2022 - Moyamoya disease (MMD) is a rare cerebrovascular disorder characterized by occlusion of bilateral internal carotid and intracerebral arteries with the compensatory growth of fragile small vessels. The etiology of disease is still unclear. The path...

RNF213 Variants and Collateral Vessels in Moyamoya Disease
https://clinicaltrials.gov/ct2/show/NCT04906564

Feb 17th, 2022 - Moyamoya disease (MMD) is a chronic cerebrovascular disorder characterized by the presence of occlusion which occurs at the internal carotid arteries and their main branches during the development of a basal collateral network. The ring finger 213...

NIRS to Evaluate Haemodynamic Reserve in Paediatric Moyamoya
https://clinicaltrials.gov/ct2/show/NCT05160454

Dec 16th, 2021 - Moyamoya disease is a cerebrovascular condition in which there is chronic brain hypoperfusion. As surgery can possibly augment brain blood flow, a method for evalutaing cerebrovascualr reserve would be helpful in selecting patients for interventio...

see more →

News  6 results

Breast Cancer Cells Use Newfound Pathway to Survive Low Oxygen Levels in Tumors
https://www.onclive.com/view/breast-cancer-cells-use-newfound-pathway-to-survive-low-oxygen-levels-in-tumors

Dec 20th, 2020 - Researchers have identified a new signaling pathway that helps cancer cells cope with the lack of oxygen found inside tumors. These are the results of a study published in Nature Cell Biology on June 20, and led by researchers at NYU Langone Medic...

Fast Five Quiz: Intracranial Hemorrhage
https://reference.medscape.com/viewarticle/909548_2

May 1st, 2019 - Although trauma is the most common cause of ICH, ICH can develop from nontraumatic etiologies. Hypertensive damage to blood vessel walls (eg, hypertension, eclampsia, drug abuse) is the most common cause of nontraumatic ICH. Other, less common non...

EDAS Surgery May Help Prevent Repeat Strokes from Brain Plaques
https://www.medpagetoday.com/cardiology/strokes/75797

Oct 18th, 2018 - For patients with a recent stroke or transient ischemic attack (TIA) attributed to intracranial atherosclerosis, a procedure to redirect scalp or dural arteries into the brain appeared to safely reduce risk of recurrent events in a phase IIa trial...

Intravenous tPA ups mortality in children with acute ischemic stroke
https://www.mdedge.com/clinicianreviews/article/138456/pediatrics/intravenous-tpa-ups-mortality-children-acute-ischemic
Sharon Worcester

May 17th, 2017 - BOSTON – Intravenous thrombolysis with tissue plasminogen activator (tPA) is associated with adverse outcomes, including an increased risk of death, in children with acute ischemic stroke, based on a review of cases from the 2006-2010 Nationwide I.

Pediatric Stroke Guidelines Emphasize Differences from Adult Care
https://www.medpagetoday.com/cardiology/strokes/10168

Jul 17th, 2008 - Action Points Explain to interested patients that stroke can occur in childhood, particularly in the first year of life. Consider using the guidelines in treatment of children who have a stroke as well as those with stroke risk factors, such as si...

see more →

Patient Education  6 results see all →